Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 6;12(1):119.
doi: 10.3390/microorganisms12010119.

Phage Lytic Protein CHAPSH3b Encapsulated in Niosomes and Gelatine Films

Affiliations

Phage Lytic Protein CHAPSH3b Encapsulated in Niosomes and Gelatine Films

Verdiana Marchianò et al. Microorganisms. .

Abstract

Antimicrobial resistance (AMR) has emerged as a global health challenge, sparking worldwide interest in exploring the antimicrobial potential of natural compounds as an alternative to conventional antibiotics. In recent years, one area of focus has been the utilization of bacteriophages and their derivative proteins. Specifically, phage lytic proteins, or endolysins, are specialized enzymes that induce bacterial cell lysis and can be efficiently produced and purified following overexpression in bacteria. Nonetheless, a significant limitation of these proteins is their vulnerability to certain environmental conditions, which may impair their effectiveness. Encapsulating endolysins in vesicles could mitigate this issue by providing added protection to the proteins, enabling controlled release, and enhancing their stability, particularly at temperatures around 4 °C. In this work, the chimeric lytic protein CHAPSH3b was encapsulated within non-ionic surfactant-based vesicles (niosomes) created using the thin film hydrating method (TFH). These protein-loaded niosomes were then characterized, revealing sizes in the range of 30-80 nm, zeta potentials between 30 and 50 mV, and an encapsulation efficiency (EE) of 50-60%. Additionally, with the objective of exploring their potential application in the food industry, these endolysin-loaded niosomes were incorporated into gelatine films. This was carried out to evaluate their stability and antimicrobial efficacy against Staphylococcus aureus.

Keywords: antimicrobial activity; encapsulation; endolysin; gelatine films; niosomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Thin film hydration method used for the synthesis of niosomes containing the lytic protein CHAPSH3b.
Figure 2
Figure 2
Particle size distribution of niosomes prepared in (A) pure Milli-Q water and (B) PBS obtained by DLS.
Figure 3
Figure 3
TEM images of niosomes stained with 2% (w/v) phosphotungstic acid (PTA). (A) Empty niosomes in water; (B) protein-loaded niosomes in water; (C) empty niosomes in PBS; (D) protein-loaded niosomes in PBS.
Figure 4
Figure 4
Protein elution profiles obtained after measurement of the absorbance at 280 nm (A280) of fractions eluted by exclusion chromatography of CHAPSH3b: 4, 8, and 12 µM in ultrapure water (A) and in PBS (B).
Figure 5
Figure 5
Elution profiles of fractions obtained by molecular exclusion chromatography of the solvent (ethanol), empty niosomes, and protein/niosomes/solvent after measurement at (A) different wavelengths (blue line: 224, green line: 254, and red line: 280 nm), and (B) different fractions at 254 nm. Red line: protein CHAPSH3b, green line: mixture of empty niosomes (1/3) and protein (2/3) solution; blue line: mixture of empty niosomes (2/3) and protein (1/3) solution. The green arrow indicates the CHAPSH3b fraction.
Figure 6
Figure 6
HPSEC chromatographs (at 280 nm) for different samples eluted in ultrapure water (A) and in PBS (B). Protein-loaded niosomes were first separated from the supernatant (blue line), and then the niosomes were broken (green line) to release CHAPSH3b. A mixture of supernatant and broken niosomes (total protein) was also analyzed (red line).
Figure 7
Figure 7
Analysis by SEM of gelatine films obtained with (A) PBS alone, (B) empty niosomes, (C) free protein, and (D) niosomes loaded with protein.

References

    1. WHO . Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis. WHO; Geneva, Switzerland: 2017.
    1. European Centre for Disease Prevention and Control . Antimicrobial Resistance Surveillance in Europe. European Centre for Disease Prevention and Control; Solna, Sweden: 2022.
    1. Pinto R.M., Lopes-De-Campos D., Martins M.C.L., Van Dijck P., Nunes C., Reis S. Impact of Nanosystems in Staphylococcus Aureus Biofilms Treatment. FEMS Microbiol. Rev. 2019;43:622–641. doi: 10.1093/femsre/fuz021. - DOI - PMC - PubMed
    1. Smith A.W. Biofilms and Antibiotic Therapy: Is There a Role for Combating Bacterial Resistance by the Use of Novel Drug Delivery Systems? Adv. Drug Deliv. Rev. 2005;57:1539–1550. doi: 10.1016/j.addr.2005.04.007. - DOI - PubMed
    1. Hatfull G.F., Dedrick R.M., Schooley R.T. Phage Therapy for Antibiotic-Resistant Bacterial Infections. Annu. Rev. Med. 2022;73:197–211. doi: 10.1146/annurev-med-080219-122208. - DOI - PubMed

LinkOut - more resources